… rivaroxaban was as effective as dabigatran, but was more effective than warfarin for the
prevention of stroke… risk was significantly higher with rivaroxaban than with dabigatran, as was all-…

… dose of rivaroxaban (20 mg/15 mg) versus dabigatran (150 mg/… associated stroke risk between
rivaroxaban and dabigatran. … stroke for dabigatran 110 mg compared with rivaroxaban 15 …

… The comparative effects of dabigatran and rivaroxaban treatment could be different in … -naive
first-time users of dabigatran or rivaroxaban for stroke prevention in AF. Results could differ …

… warfarin, apixaban, dabigatran, and rivaroxaban, have recently … 2 of the 4 therapies for stroke
prevention in patients in the … cost-effectiveness of stroke prevention in patients with NVAF in …

… risk of stroke and systemic embolism (by 26%) for dabigatran (150 mg twice daily [bid])
compared with rivaroxaban, as well as haemorrhagic stroke and non-disabling stroke. There …

… dabigatran and rivaroxaban. We found no difference in stroke prevention between rivaroxaban
and dabigatran… of thromboembolic events other than stroke were higher with rivaroxaban. …

… This study aimed to evaluate the cost-effectiveness of dabigatran and rivaroxaban … -utility
of dabigatran and rivaroxaban compared with warfarin for the prevention of stroke in patients …

… for stroke prevention … ), dabigatran (Pradaxa), for prevention of stroke and systemic
embolism in patients with nonvalvular AF (NVAF). An oral factor Xa inhibitor, rivaroxaban (Xarelto), …

… This study found dabigatran is economically dominant versus rivaroxaban for prevention of
stroke and systemic embolism among … rivaroxaban in a previously published model of stroke …

… stroke prevention in AF, dabigatran and apixaban are administered twice daily, and rivaroxaban
… Efficacy and safety of NOACs versus VKAs for stroke prevention in patients with AF were …